Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.

Source:http://linkedlifedata.com/resource/pubmed/id/20385862

Download in:

View as

General Info

PMID
20385862